133 related articles for article (PubMed ID: 8546180)
1. Advanced glycation end products are associated with beta 2-microglobulin amyloidosis.
Miyazaki S; Niwa T; Morita T; Koda Y; Yuasa Y; Sakai S; Suzuki M; Takahashi S; Hirasawa Y
Am J Nephrol; 1995; 15(6):535-6. PubMed ID: 8546180
[No Abstract] [Full Text] [Related]
2. Immunohistochemical localization of beta 2-microglobulin and advanced glycation end products in amyloid-enriched carpal tunnel ligament.
Morita H; Shinzato T; Cai Z; Horiuchi S; Maeda K
Nephron; 1996; 73(1):117-8. PubMed ID: 8742979
[No Abstract] [Full Text] [Related]
3. Beta2-Microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end products.
Niwa T
Nephron; 1997; 76(4):373-91. PubMed ID: 9274834
[No Abstract] [Full Text] [Related]
4. Beta2-microglobulin and renal bone disease.
Wada T; Miyata T; Sakai H; Kurokawa K
Perit Dial Int; 1999; 19 Suppl 2():S413-6. PubMed ID: 10406556
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis.
Miyata T; Sprague SM
Nephrol Dial Transplant; 1996; 11 Suppl 3():86-90. PubMed ID: 8840320
[No Abstract] [Full Text] [Related]
6. New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction.
Miyata T; Maeda K
Nephrol Dial Transplant; 1996; 11 Suppl 2():140-3. PubMed ID: 8804015
[No Abstract] [Full Text] [Related]
7. Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid.
Ehlerding G; Schaeffer J; Drommer W; Miyata T; Koch KM; Floege J
Nephrol Dial Transplant; 1998 Jun; 13(6):1465-75. PubMed ID: 9641177
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-microglobulin modified with the AGE products of the Maillard reaction in dialysis-related amyloidosis.
Miyata T; Wada Y; Maeda K
Contrib Nephrol; 1995; 112():52-64. PubMed ID: 7554993
[No Abstract] [Full Text] [Related]
9. Pathogenesis of dialysis-related amyloidosis.
Miyata T; Maeda K
Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):493-7. PubMed ID: 8591057
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y
J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487
[TBL] [Abstract][Full Text] [Related]
11. beta2-microglobulin-derived amyloidosis: an update.
Floege J; Ketteler M
Kidney Int Suppl; 2001 Feb; 78():S164-71. PubMed ID: 11169004
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and amyloidosis.
Ando Y; Suhr O; el-Salhy M
Histol Histopathol; 1998 Jul; 13(3):845-50. PubMed ID: 9690141
[TBL] [Abstract][Full Text] [Related]
14. Beta-2 microglobulin in ESRD: an in-depth review.
Winchester JF; Salsberg JA; Levin NW
Adv Ren Replace Ther; 2003 Oct; 10(4):279-309. PubMed ID: 14681859
[TBL] [Abstract][Full Text] [Related]
15. [Morphology and diagnosis of hemodialysis--related amyloidosis].
Ohashi K; Kawai R; Hara M
Nihon Rinsho; 1992 Jan; 50 Suppl():801-6. PubMed ID: 1578770
[No Abstract] [Full Text] [Related]
16. Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis.
Hou FF; Chertow GM; Kay J; Boyce J; Lazarus JM; Braatz JA; Owen WF
Kidney Int; 1997 May; 51(5):1514-9. PubMed ID: 9150467
[TBL] [Abstract][Full Text] [Related]
17. beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
Miyata T; Oda O; Inagi R; Iida Y; Araki N; Yamada N; Horiuchi S; Taniguchi N; Maeda K; Kinoshita T
J Clin Invest; 1993 Sep; 92(3):1243-52. PubMed ID: 8376584
[TBL] [Abstract][Full Text] [Related]
18. Aberrant cytokine production from tenosynovium in dialysis associated amyloidosis.
Miyasaka N; Sato K; Kitano Y; Higaki M; Nishioka K; Ohta K
Ann Rheum Dis; 1992 Jun; 51(6):797-802. PubMed ID: 1616367
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
Miyata T; Inagi R; Kurokawa K
Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
[TBL] [Abstract][Full Text] [Related]
20. Does dialysis-associated amyloidosis resolve after transplantation?
Nelson SR; Sharpstone P; Kingswood JC
Nephrol Dial Transplant; 1993; 8(4):369-70. PubMed ID: 7685506
[No Abstract] [Full Text] [Related]
[Next] [New Search]
